[6] YANG Z Y. Effect analysis on exenatide combined with insulin aspart in blood glucose control [J]. Chin Modern Doctor(中国现代医生), 2016, 54(6): 29-33. [7] ZHANG P, PAN T R, ZHONG X, et al. Efficacy and safety observation of liraglutide and insulin as combination therapy in ...
Effects of liraglutide observation of liraglutide and insulin as combination therapy and Novorapid 30 on the glycometabolism, islet function and in the treatment of newly diagnosed type 2 diabetes with biochemical indexes of patients with type 2 diabetes mellitus obesity [J]. Chin J Diabetes( 中国...
D.M., Roberts, A., et al. 2007. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. Clin Ther 29...
D.M., Roberts, A., et al. 2007. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two...
[19] Thorkildsen, C., Neve, S., Larsen, B.D., Meier, E., Petersen, J.S. 2003. Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice. J Pharmacol Exp Ther 307:490-496. ...
nB.Gutpeptidesandtype2diabetesmellitustreatment.CurrDi abRep.2003;3:365–372.3. ZanderM,MadsbadS,MadsenJL,Holst JJ.Effectof6-weekcourseofglucagon-likepeptide1onglycaem iccontrol,insulinsensitivity,andβ-cellfunctionintype2di abetes:Aparallel-groupstudy.Lancet.2002;359:824–830.4. Druc ...
A combined therapy for diabetes is disclosed herein, comprising one or more first effective components selected from the group consisting of the first effective amounts of GLP-1 and GLP-1 analogues, and one or more second effective components selected from the group consisting of insulin and ...
Integrated incremental immunoreactive insulin and connecting peptide responses to an oral glucose load of 50 g and an isoglycaemic intravenous glucose infusion, respectively, were measured in 14 Type 2 non-insulin-dependent diabetic patients and 8 age- and weight-matched metabolically healthy control ...
9、Chuang EY et al. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT. Biomaterials. 2013 Oct;34(32):7994-8001. 台湾国立清华大学的Chuang EY等人采用由壳聚糖与聚(γ-谷氨酸)构成的载体制备了同时装载有艾塞那...
11.6+/-1.7%)ondietandsulphonylureatherapy(insomepatient ssupplementedbymetforminoracarbose),1.2pmolxkg-1xmin-1 GLP-1(7-36amide)orplacebowasinfusedintravenouslyinthef astingstate(plasmaglucose13.1+/-0.6mmol/l).Inallpatient s,insulin(by17.4+/-4.7nmolx1-1xmin;p=0.0157)andC-p ...